Search

9022 results for: ‘thinkphp3.2.3仿快乐麻花官网 thinkphp笑话网站源码 php带移动端wap笑话网站源码下载。✅项目合作 二开均可 TG:saolei44✅.SazKBXWMua’

  • Bradgate Park Fieldschool Season 2 (2016)

    A summary of year 2 of the Bradgate Park archaeological fieldschool in Leicestershire

  • Spanish Post-beginners Fast Track (Level 2)

    Fast Track Spanish course for post-beginners at Leicester University

  • Stephen Walker: Page 2

    Stephen is an Educational Development Adviser with the Leicester Learning Institute and works closely with colleagues across the university to provide a range of support and training services.

  • Study reviews new once-weekly Type 2 diabetes drugs

    Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in their efficacy and safety profiles, according to new research by researchers from the Leicester Diabetes Centre. Compared to other once-weekly GLP-1RAs which are licensed and available, dulaglutide 1.

  • Signs of early heart failure revealed in patients with type 2 diabetes

    Adults with type 2 diabetes that have no history, signs or symptoms of heart problems have been shown to have severely limited exercise capacity.

  • Weight loss drug hope for patients with type 2 diabetes

    Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.

  • Meet SpaceX Demo-2 Astronauts Bob and Doug – National Space Centre Q&A

    Posted by Physics & Astronomy in Physics and Astronomy Blog on 20 January 2021 Join our National Space Centre colleagues for a LIVE Space Astronaut Q&A with SpaceX Demo-2 Astronauts Robert L. Behnken and Douglas G. Hurley, this Friday 22 January 19:00-20:00.

  • Medicine offers weight-loss hope for patients with type-2 diabetes

    New research by academics at the University of Leicester published today (Friday) has given fresh hope to patients with type-2 diabetes, after Eli Lilly and Company’s SURPASS-2 clinical trial showed that 60% of patients achieved a 10% percent or greater weight loss with 15 mg...

  • Martin Coffey: Page 2

    Postgraduate Career Development Adviser, Doctoral College Team.

  • Stephen Wood: Page 2

    Professor of Management

Back to top
MENU